111426 people have viewed this drug in the last 60 days
Updated 2025-10-03
Last Update | 2022-08-29 |
Register Year | 2019 |
Product Type | Human |
Drug Type | Biological |
Scientific Name | RITUXIMAB |
Trade Name | MABTHERA 119.4 MG SOLUTION FOR SUBCUTANEOUS INJECTION |
Strength Unit | mg |
Pharmaceutical Form | Concentrate and diluent for solution for infusion |
Administration Route | Subcutaneous use |
Atc Code1 | L01XC02 |
Atc Code2 | |
Size | 13.4 |
Size Unit | ml |
Package Types | Vial |
Package Size | 1 |
Legal Status | Prescription |
Product Control | Uncontrolled |
Distribute Area | Hospital |
Public price | $8037.25 |
Shelf Life | 30 Months |
Marketing Company | ROCHE |
Marketing Country | Switzerland |
Manufacture Name | F. Hoffmann-La Roche Ltd. |
Manufacture Country | Switzerland |
Secondry package manufacture | |
Main Agent | ARAC HEALTHCARE |
Secosnd Agent | |
Third Agent | |
Visits | 111426 |
Do not forget, after purchasing the medicine, help us determine the price more accurately, press the button below and adjust the price directly
Name | Price | Visits | Updated |
---|---|---|---|
Ruxience 500 mg per 50 ml | $2276.1 | 100308 visits | 2023-02-16 |
Ruxience 100 mg per 10 ml | $455.6 | 11038 visits | 2023-02-02 |
MABTHERA 119.4 MG SOLUTION FOR SUBCUTANE | $8037.25 | 111426 visits | 2022-08-29 |
MABTHERA 120 MG/ML SOLUTION FOR SUBCUTAN | $7032.6 | 169569 visits | 2022-08-29 |